Hi all,What does the global bioeconomy look like in 5, 10 or 20 years? What are the key cases of microbial-enabled manufacturing, how should they evolve in the coming years? Last year, fifty companies raised over $1.7 billion for the development of innovative synthetic biology technologies, check out our market map of them below. Join the discussion this October at SynBioBeta 2018 with code DIGEST by the end of the day to save $50.

Today, Engine Biosciences, a company whose team members include Tim Lu and Jim Collins from MIT, announced a $10 Million Series A financing to combine artificial intelligence and genomics to redesign drug discovery.The next generation DNA synthesis market is heating up as Evonetix raised a $12.3 million (£9 million) Series A led by DCVC to develop technology that enables the parallel synthesis of DNA on silicon arrays. Paris-based DNA Script also announced an agreement with Dynamic Combinatorial Chemistry (DCC) to advance its enzymatic technology to synthesize long DNA fragments, towards entire genes and, eventually, chromosomes.

Hermann Hauser and Matt Ocko, Evonetix Investors.Clean meat company Memphis Meats received investment from Tyson Foods’ venture capital arm. Tyson joins other top investors including Bill Gates and Richard Branson.

I hope you have a great week.

Regards,John

Who's Hiring?

PhD position with a focus on metabolic engineering and bioprocess development: Biosyntia, DenmarkProduct Scientist: Opentrons, New YorkSenior Scientist, Strain Engineering: Amyris, Emeryville, CaliforniaSenior Scientist, Enzyme Engineering: Amyris, Emeryville, CaliforniaScientist, Cytochrome P450 Engineering: Amyris, Emeryville, CaliforniaScientist, Strain Performance Optimization, PD&E: Amyris, Emeryville, CaliforniaSenior Director, Separations Process Development: Amyris, Emeryville, CaliforniaTo feature your job here, please get in touch

News

Sphere Fluidics expands Cyto-Mine (Single Cell Analysis System) sales team and distribution in US, Europe and AsiaResponsible and Sustainable Synthetic Biology in AfricaMicrobiome Company BiomX Licenses Novel Bacterial Targets for the Treatment of Inflammatory Bowel DiseaseDEINOVE and Oléos, partners in the development of a new cosmetic active ingredientHow synthetic spider silk could change everything you wearFor postdocs looking to break into entrepreneurship, this MIT fellowship is helping light the wayRainbow Seed Fund Changes Name to UK Innovation Science & Seed FundEngineered bacteria to detect gut inflammation (PLOS SynBio)3 Promising Alternative Feeds for AquacultureBIO welcomes new Industrial & Environmental Section members

Copyright © %%current_year_YYYY%%, All rights reserved.SynBioBeta1547 Palos Verdes Mall, #411Walnut Creek, CA 94597About Us | Update Preferences | Unsubscribe | View email in your browser